help  | about  | cite  | software

Publication : PICALM modulates autophagy activity and tau accumulation.

First Author  Moreau Kevin Year  2014
Journal  Nat Commun Volume  5
Pages  4998 PubMed ID  25241929
Abstract Text  Genome-wide association studies have identified several loci associated with Alzheimer's disease (AD), including proteins involved in endocytic trafficking such as PICALM/CALM (phosphatidylinositol binding clathrin assembly protein). It is unclear how these loci may contribute to AD pathology. Here we show that CALM modulates autophagy and alters clearance of tau, a protein which is a known autophagy substrate and which is causatively linked to AD, both in vitro and in vivo. Furthermore, altered CALM expression exacerbates tau-mediated toxicity in zebrafish transgenic models. CALM influences autophagy by regulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have diverse effects on different stages of the autophagy pathway, from autophagosome formation to autophagosome degradation. This study suggests that the AD genetic risk factor CALM modulates autophagy, and this may affect disease in a number of ways including modulation of tau turnover. Doi  10.1038/ncomms5998
Month  Sep

Publication Annotations Displayer

15 Entities

24 Mesh Terms